|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007320,
umls-concept:C0013303,
umls-concept:C0017181,
umls-concept:C0022378,
umls-concept:C0023866,
umls-concept:C0036974,
umls-concept:C0085973,
umls-concept:C0162678,
umls-concept:C0205263,
umls-concept:C0205420,
umls-concept:C0206695,
umls-concept:C0238198,
umls-concept:C0282443,
umls-concept:C1552617
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-3-14
|
|
pubmed:abstractText |
The incidence of neuroendocrine tumors (NET) and of gastrointestinal stromal tumors (GIST) is 0.5 and 1 - 2 in 100,000; the prevalence of neurofibromatosis is 1 in 3000 live births in Western countries.
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0044-2771
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
281-8
|
|
pubmed:dateRevised |
2009-11-11
|
|
pubmed:meshHeading |
pubmed-meshheading:15765301-Adult,
pubmed-meshheading:15765301-Antineoplastic Agents,
pubmed-meshheading:15765301-Carcinoma, Neuroendocrine,
pubmed-meshheading:15765301-Clinical Trials, Phase I as Topic,
pubmed-meshheading:15765301-Clinical Trials, Phase II as Topic,
pubmed-meshheading:15765301-Duodenal Neoplasms,
pubmed-meshheading:15765301-Duodenum,
pubmed-meshheading:15765301-Female,
pubmed-meshheading:15765301-Follow-Up Studies,
pubmed-meshheading:15765301-Gastrointestinal Hemorrhage,
pubmed-meshheading:15765301-Gastrointestinal Stromal Tumors,
pubmed-meshheading:15765301-Humans,
pubmed-meshheading:15765301-Immunohistochemistry,
pubmed-meshheading:15765301-Jejunal Neoplasms,
pubmed-meshheading:15765301-Neurofibromatosis 1,
pubmed-meshheading:15765301-Piperazines,
pubmed-meshheading:15765301-Protein Kinase Inhibitors,
pubmed-meshheading:15765301-Pyrimidines,
pubmed-meshheading:15765301-Shock, Hemorrhagic,
pubmed-meshheading:15765301-Time Factors,
pubmed-meshheading:15765301-Tomography, Spiral Computed,
pubmed-meshheading:15765301-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
[GI hemorrhage with fulminant shock induced by jejunal gastrointestinal stromal tumor (GIST) coincident with duodenal neuroendocrine carcinoma (NET) + neurofibromatosis (NF) -- case report and review of the literature].
|
|
pubmed:affiliation |
Klinik für Chirurgie I, Universitätsklinikum Ulm. kramer.k@web.de
|
|
pubmed:publicationType |
Comparative Study,
English Abstract,
Case Reports,
Lectures
|
